595 related articles for article (PubMed ID: 23020295)
1. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.
Morisseau C; Hammock BD
Annu Rev Pharmacol Toxicol; 2013; 53():37-58. PubMed ID: 23020295
[TBL] [Abstract][Full Text] [Related]
2. Epoxides and soluble epoxide hydrolase in cardiovascular physiology.
Imig JD
Physiol Rev; 2012 Jan; 92(1):101-30. PubMed ID: 22298653
[TBL] [Abstract][Full Text] [Related]
3. Epoxide hydrolase activities and epoxy fatty acids in the mosquito Culex quinquefasciatus.
Xu J; Morisseau C; Yang J; Mamatha DM; Hammock BD
Insect Biochem Mol Biol; 2015 Apr; 59():41-9. PubMed ID: 25686802
[TBL] [Abstract][Full Text] [Related]
4. Measurement of soluble epoxide hydrolase (sEH) activity.
Morisseau C; Hammock BD
Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.23. PubMed ID: 23045145
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.
Atone J; Wagner K; Hashimoto K; Hammock BD
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106385. PubMed ID: 31698143
[TBL] [Abstract][Full Text] [Related]
6. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
7. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
8. Targeting epoxides for organ damage in hypertension.
Imig JD
J Cardiovasc Pharmacol; 2010 Oct; 56(4):329-35. PubMed ID: 20531214
[TBL] [Abstract][Full Text] [Related]
9. Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation.
Kodani SD; Morisseau C
Biochimie; 2019 Apr; 159():59-65. PubMed ID: 30716359
[TBL] [Abstract][Full Text] [Related]
10. Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth.
Oguro A; Sakamoto K; Suzuki S; Imaoka S
Biol Pharm Bull; 2009 Dec; 32(12):1962-7. PubMed ID: 19952412
[TBL] [Abstract][Full Text] [Related]
11. Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.
Elmarakby AA
Am J Physiol Regul Integr Comp Physiol; 2012 Feb; 302(3):R321-30. PubMed ID: 22116511
[TBL] [Abstract][Full Text] [Related]
12. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
13. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
Frömel T; Hu J; Fleming I
Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor.
Smith KR; Pinkerton KE; Watanabe T; Pedersen TL; Ma SJ; Hammock BD
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2186-91. PubMed ID: 15684051
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of an epoxide hydrolase from Anopheles gambiae with high activity on epoxy fatty acids.
Xu J; Morisseau C; Hammock BD
Insect Biochem Mol Biol; 2014 Nov; 54():42-52. PubMed ID: 25173592
[TBL] [Abstract][Full Text] [Related]
16. Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
Takai K; Nakajima T; Takanashi Y; Sone T; Nariai T; Chiyo N; Nakatani S; Ishikawa C; Yamaguchi N; Fujita K; Yamada K
Bioorg Med Chem; 2014 Mar; 22(5):1548-57. PubMed ID: 24530032
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
Spector AA; Fang X; Snyder GD; Weintraub NL
Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
[TBL] [Abstract][Full Text] [Related]
18. Epoxyeicosatrienoic acids and soluble epoxide hydrolase in physiology and diseases of the central nervous system.
Kuo YM; Lee YH
Chin J Physiol; 2022; 65(1):1-11. PubMed ID: 35229747
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade.
Iyer MR; Kundu B; Wood CM
Expert Opin Ther Pat; 2022 Jun; 32(6):629-647. PubMed ID: 35410559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
